Looks like their really hurting for that cash from Lizada. I'm not really sure about the math of the trade, but Lizada is supposedly buying a large chunk of the company for $15 million. I'm curious what their valuation is. With that $15 million, their supposedly to get 22,160,000 shares total with a combination of restricted, preferred, and common shares. Incidentally, shortly after that announcement came out by the founder, Medbox the company put out a statement that "the company has not reviewed or finalized the agreement as of yet". Seems like the two sides aren't talking much to each other.
